NEW YORK, April 5, 2024 /PRNewswire/ -- Luvme Hair, a leading brand in the human hair wigs industry, is thrilled to announce its upcoming event - the Luvme Pop-Up Shop in Houston, Texas. This event will run from April 12 -14, 2024, following the resounding success of the brand's previous NYC Pop-Up Shop.
"We're thrilled to be opening this new pop-up shop in Houston," said Helena Lee, founder of Luvme Hair. "Our previous NYC pop-up has been a massive hit, and we can't wait to bring the same excitement and high-quality experience to the vibrant city of Houston."
During the 3-day #LUVMEPOPUP Houston event, attendees can expect:
Complimentary 1-on-1 Styling Sessions: Expert hairstylists will be on-site, offering personalized styling services for Luvme Hair units, ensuring that attendees leave with the perfect look (limited to 30 spots daily).
Over 5,000 Gifts Await Attendees: Exciting surprises are ready for attendees to claim.
In-Store Giveaway: Attendees will have the chance to win cash through an in-store giveaway.
For more Houston pop-up store information and to stay up-to-date with Luvme Hair events and experiences, please visit the Luvme Hair website and follow us on Instagram and TikTok.
About Luvme Hair
Luvme Hair is a reputable brand in the hair industry, known for its high-quality human hair, glueless wigs, HD lace wigs, PartingMax Glueless Wigs, and wigs that allow individuals to effortlessly switch up their looks. With a focus on innovation, creativity, quality, and customer satisfaction, Luvme Hair has garnered a loyal customer base globally, with over 1 million satisfied customers all over the world. For more information about Luvme Hair and its products, please visit their official website at shop.luvmehair.com.
Flow Capital Corp. ("Flow Capital"), a leading provider of flexible growth capital solutions, is pleased to announce the full repayment of a USD 4.5 million investment in an environmental solutions provider. Flow Capital continues to focus on...
bluebird bio, Inc. announced today that it will host a conference call to discuss first quarter 2024 results and business updates on May 9, at 8:00 a.m. ET.
To participate in the conference call, please dial +1 (800) 715-9871 (U.S. and Canada) and...
Stoke Therapeutics, Inc. , a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today reported financial results for the first quarter of 2024 and...
Total 1Q 2024 net product revenue of $75.0 million, representing 160% year-over-year growth Auvelity® 1Q 2024 net product sales of $53.4 million, representing 240% year-over-year growth Sunosi® 1Q 2024 net product revenue of $21.6 million...